2025-05-15 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc (TDOC) based on the data you provided.

**Report on Teladoc Health Inc (TDOC)**

**0) Introduction**

This report analyzes Teladoc Health Inc (TDOC) using provided financial data, technical indicators, news, and earnings reports. The analysis includes a comparison against the S&P 500 (VOO) and considers recent market events.

**1) Performance vs. S&P 500 (VOO)**

*   **Ticker:** TDOC
*   **Company:** Teladoc Health Inc
*   **Description:** Teladoc Health Inc. is a telehealth company that provides virtual healthcare services.
*   **TDOC Cumulative Return:** 0.0
*   **VOO Cumulative Return:** 0.0
*   **Divergence:**
    *   Max: 0.0
    *   Min: 0.0
    *   Current: 0.0
    *   Relative Divergence: 0.0

*   **Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 0.0% | 0.0% | 0.0%  | 1.0  | 5.9   |
| 2016-2018  | 0.0% | 0.0% | 0.0%  | 1.0  | 8.4   |
| 2017-2019  | 0.0% | 0.0% | 0.0%  | 1.0  | 14.2  |
| 2018-2020  | 0.0% | 0.0% | 0.0%  | 1.0  | 34.0  |
| 2019-2021  | 0.0% | 0.0% | 0.0%  | 1.0  | 15.6  |
| 2020-2022  | 0.0% | 0.0% | 0.0%  | 1.0  | 4.0   |
| 2021-2023  | 0.0% | 0.0% | 0.0%  | 1.0  | 3.7   |
| 2022-2024  | 0.0% | 0.0% | 0.0%  | 1.0  | 1.6   |
| 2023-2025  | 0.0% | 0.0% | 0.0%  | 1.0  | 1.3   |

**Analysis:**
*   The data is showing a Beta of 1.0 across all periods, suggesting that TDOC's volatility is similar to the overall market. Alpha is consistently 0.0, indicating no outperformance relative to the market based on this model. The market cap data shows growth and decline over the years.

**2) Recent Price Action**

*   **Current Price:** 7.619999885559082
*   **Last Market Data:** {'price': 7.41, 'previousClose': 7.62, 'change': -2.76}
*   **5-Day Moving Average:** 7.204
*   **20-Day Moving Average:** 7.0745
*   **60-Day Moving Average:** 8.3787

**Analysis:** The current price is below the 60-day moving average but above the 5-day and 20-day averages, suggesting a potential short-term uptrend. The recent market data shows a negative change of -2.76%, indicating a downward pressure.

**3) Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.0 (Low Risk threshold: 0.45~0.35)
*   **RSI:** 62.6728012374031 (Above 50, indicating bullish momentum)
*   **PPO:** 1.5937 (Positive, suggesting an uptrend)
*   **Recent (20-day) Relative Divergence Change:** 0.0 (Neutral trend)
*   **Expected Return (%):** 0.0 (No expected outperformance vs. S&P 500)

**Analysis:**  The RSI suggests bullish momentum, and the PPO confirms an uptrend. However, the Market Risk Indicator is low. The recent price drop ({'price': 7.41, 'previousClose': 7.62, 'change': -2.76}) should be considered a short-term negative catalyst.

**4) Recent News & Significant Events**

*   **2025-05-15:** Major business developments, regulatory changes, or market events.
*   **2025-05-14:** Analyst discussions on performance and outlook.
*   **2025-05-11:** Stock volatility due to recent news, earnings, or executive actions.
*   **2025-05-12:** Experts highlight risks and opportunities.

**Analysis:** Recent news indicates volatility and significant events affecting TDOC. Investors should closely monitor company announcements and industry trends.

**5) Recent Earnings Analysis**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-05-01 | -0.53 | 0.63 B$   |
| 2024-10-31 | -0.19 | 0.64 B$   |
| 2024-08-01 | -4.92 | 0.64 B$   |
| 2024-04-26 | -0.49 | 0.65 B$   |
| 2025-05-01 | -0.49 | 0.65 B$   |

**Analysis:** TDOC has reported negative EPS across the recent quarters. While revenue has been relatively stable around $0.63-0.65 billion, the large negative EPS in 2024-08-01 is concerning.

**6) Financial Information**

Revenue and Profitability:

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $0.63B   | 68.73%        |
| 2024-12-31 | $0.64B   | 70.50%        |
| 2024-09-30 | $0.64B   | 71.94%        |
| 2024-06-30 | $0.64B   | 70.73%        |
| 2024-03-31 | $0.65B   | 69.89%        |

Capital and Profitability:

| Quarter    | Equity   | ROE      |
|------------|----------|----------|
| 2025-03-31 | $1.43B   | -6.52%   |
| 2024-12-31 | $1.49B   | -3.25%   |
| 2024-09-30 | $1.51B   | -2.21%   |
| 2024-06-30 | $1.50B   | -55.77%  |
| 2024-03-31 | $2.29B   | -3.58%   |

**Analysis:** Revenue has been relatively stable. Profit margins are strong, indicating efficiency in operations. However, the company has negative ROE values, indicating that it is not generating profits from its equity. The sharp decrease in equity from Q1 2024 to Q2 2024 and the highly negative ROE in Q2 2024 are major concerns.

**7) Overall Analysis & Conclusion**

Teladoc Health Inc. (TDOC) faces significant challenges.

*   **Financials:** While revenue is consistent and profit margins are high, negative EPS and ROE are concerning. The equity decline and large EPS loss in mid-2024 raise red flags.
*   **Technicals:** The RSI and PPO indicators suggest a possible short-term bullish trend. However, the recent price drop indicates ongoing volatility.
*   **Market Sentiment:** Recent news points to market events and volatility, requiring close monitoring.
*   **Performance vs. S&P 500:** The lack of alpha suggests the stock is not outperforming the market.
*   **Risk:** The negative ROE and earnings coupled with market volatility suggest a high-risk investment.

**Recommendation:** Based on the current data, a cautious approach to TDOC is warranted. Further investigation into the reasons behind the negative earnings and equity decline is crucial before considering an investment. Monitoring upcoming earnings reports and company announcements is advisable.
